Statins linked with lower mortality risk in study of liver cancer

01/28/2013 | MedPage Today (free registration)

Patients with hepatocellular carcinoma who took statins, in combination with local and systemic treatments or surgical resection, had a 30% lower risk of death than non-statin users. Statin users lived for an average of 25.4 months compared with 18.5 for non-users, researchers said. The retrospective, nonrandomized study, which involved 644 patients, was presented at the Gastrointestinal Cancers Symposium.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC